Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies (Q44189206)

30 November 2017

0 references

Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies (English)

1 reference

30 November 2017

cardiovascular disease

1 reference

1 reference

Leonelo E Bautista

1

1 reference

30 November 2017

Iván A Arenas

series ordinal

2

1 reference

30 November 2017

Anderson Peñuela

series ordinal

3

1 reference

30 November 2017

Luz X Martínez

series ordinal

4

1 reference

30 November 2017

1 September 2002

1 reference

Journal of Clinical Epidemiology

30 November 2017

1 reference

30 November 2017

55

1 reference

30 November 2017

9

1 reference

30 November 2017

882-887

1 reference

Evaluating novel cardiovascular risk factors: can we better predict heart attacks?

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Serial measures of plasma homocyst(e)ine after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Plasma homocysteine in the acute and convalescent phases after stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Serum total homocysteine and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Serum total homocysteine and coronary heart disease: prospective study in middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

An alternative view of homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Preventing Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

A note on graphical presentation of estimated odds ratios from several clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Summing up evidence: one answer is not always enough.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

The controversy over homocysteine and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Homocystinemia. Vascular injury and arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2802%2900434-1

7 January 2021

10.1016/S0895-4356(02)00434-1

Identifiers

DOI

1 reference

30 November 2017

1 reference